All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @tamsenfadal on TikTok · 226s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @tamsenfadal's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00So this is the estradial patch and it changes two times a week,
  2. 0:04Monday morning and Thursday in the evening, so it gives me 3 1 half and 3 1 half each day.
  3. 0:09It's estradial, mine is a .075, so if you take a look at this, it's probably a little bit bigger
  4. 0:15if you're on a .025 or .050, so this is .075, and that's why it just looks, I don't even know what to compare it to,
  5. 0:25but like maybe my thumb. And so each side it's got, you know, sticky and I'm going to take it and I'm going to replace the one that I have on since
  6. 0:35Monday morning and I don't even know what side it's on right now, so we're going to find out together.
  7. 0:40Ah, okay, right, it's always .050, so I'm going to pull that one off and then I just switch sides and put it right here and make sure it's really secure.
  8. 0:50So this is one part of my hormone therapy. The other is the progesterone pill that I take, let me see if I have any here for you.
  9. 1:00I don't, we're going to bedroom next. And then the third is the testosterone gel, and I already did this one this morning, but this is a gel and you're going to take just about like the size of the cap,
  10. 1:18the circumference of the cap, just like this. Of course, and I want to show it to you guys. I'm not going to put it.
  11. 1:26The circumference of the cap, right about that much, you can see it, and we're going to put it on the back of my cap.
  12. 1:39That's where I put mine, and so this is like a tenth of the amount of a male's virgin, I'm sorry.
  13. 1:48This is the tenth of the amount of a man's dose because we don't have our own as women, so this is what we have, so we are using the amount that is good for us.
  14. 1:59And so I got this from my doctor, this is a prescription, this is a prescription testosterone, I'm sorry.
  15. 2:05This is a prescription, this is a prescription, and so is the progesterone. So I'm going to wash this off because I already did it today, and I don't need it again, and I'm going to go to bed.
  16. 2:15So let's go in the bedroom, and let me show you the progesterone. Now, my progesterone pills are bigger too, because I was not sleeping, I was taking them, and then I stopped sleeping, and I was just not feeling good, not feeling like myself, so those have been doubled.
  17. 2:31So I'm going to show you what they look like my little pill case. I'm going to show you what they look like.
  18. 2:36If you're taking these, they look like little circular gel things, or like white, little progesterone, and mine, so those are the 100, these are the 200, so they're a little bit bigger and they're more like an oval shape.
  19. 2:51And I take this every night before I go to bed, I put the testosterone on in the morning, I switch a patch twice a week, and then I take these every single night before I go to sleep, and I do sleep like a baby.
  20. 3:02But these are all prescribed by my doctor, and everybody is different. That's just what I do, over my hormone replacement.
  21. 3:11That's just what I do for my hormone therapy, and then of course there's one more thing. I'll show you that. I'm not going to show you that completely, but I'm going to show you that, and that is the vaginal estrogen, so that you're aware.
  22. 3:23And that, my friends, you should be talking to your doctor about. This is what mine looks like. I'm going to let you do some of the guesswork.

@tamsenfadal's perimenopause claims need more context

Tamsen Fadal

TikTok creator

14.8K viewsWatch on TikTok

Quick answer

The creator demonstrates a standard combination HRT protocol for perimenopause: transdermal estradiol (.075 mg/day patch), oral micronized progesterone (200 mg nightly), off-label low-dose testosterone gel, and vaginal estrogen. This four-component approach addresses systemic vasomotor symptoms, sleep disruption, and genitourinary symptoms of menopause concurrently. All components are prescription-only and dosing should be individualized with clinician oversight and periodic lab monitoring, particularly for testosterone.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @tamsenfadal's perimenopause claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@tamsenfadal's perimenopause claims need more context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@tamsenfadal's perimenopause claims need more context" from Tamsen Fadal. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator demonstrates a standard combination HRT protocol for perimenopause: transdermal estradiol (.

The reason this review is not generic is the source wording and the canonical claim label "trt here for you if you have any questions perimenopause hor." In this clip, the useful excerpt is: "So this is the estradial patch and it changes two times a week, Monday morning and Thursday in the evening, so it gives me 3 1 half and 3 1 half each day." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Oral micronized progesterone at 100-200 mg nightly has sedative properties tied to GABA-A receptor activity, making it distinct from synthetic progestins that do not share this mechanism (Schussler et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator demonstrates a standard combination HRT protocol for perimenopause: transdermal estradiol (.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator demonstrates a standard combination HRT protocol for perimenopause: transdermal estradiol (.075 mg/day patch), oral micronized progesterone (200 mg nightly), off-label low-dose testosterone gel, and vaginal estrogen. This four-component approach addresses systemic vasomotor symptoms, sleep disruption, and genitourinary symptoms of menopause concurrently. All components are prescription-only and dosing should be individualized with clinician oversight and periodic lab monitoring, particularly for testosterone.
  • Transdermal estradiol carries a significantly lower venous thromboembolism risk than oral estrogen formulations, a distinction supported by multiple observational studies including Canonico et al., 2007, Circulation.
  • Oral micronized progesterone at 100-200 mg nightly has sedative properties tied to GABA-A receptor activity, making it distinct from synthetic progestins that do not share this mechanism (Schussler et al., 2008, Maturitas).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Transdermal estradiol carries a significantly lower venous thromboembolism risk than oral estrogen formulations, a distinction supported by multiple observational studies including Canonico et al., 2007, Circulation.
  • Oral micronized progesterone at 100-200 mg nightly has sedative properties tied to GABA-A receptor activity, making it distinct from synthetic progestins that do not share this mechanism (Schussler et al., 2008, Maturitas).
  • There is no FDA-approved testosterone product for women in the United States as of 2024; any use is off-label and should involve baseline serum testosterone testing and follow-up monitoring per Endocrine Society guidance.
  • Women do produce endogenous testosterone from ovarian and adrenal sources; it declines substantially during perimenopause and menopause, which is distinct from having no production at all.
  • The 2002 WHI findings that discouraged HRT have been substantially reanalyzed; current evidence supports favorable benefit-risk profiles for healthy women under 60 initiating therapy within 10 years of menopause onset (Manson et al., 2013, JAMA Internal Medicine).
  • Vaginal estrogen has minimal systemic absorption and is considered safe for most women, including those with contraindications to systemic hormone therapy, per the Menopause Society 2022 position statement.
  • Any HRT regimen involving multiple hormones requires periodic lab work and clinician oversight; no combination described in a social media video should be self-initiated or self-adjusted.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @tamsenfadal actually say?

She walks viewers through a three-part hormone therapy regimen she uses for perimenopause: an estradiol patch (.075 mg/day, changed twice weekly), oral micronized progesterone (100 mg bumped to 200 mg due to sleep issues), and a testosterone gel applied to the back of her hand each morning. She also briefly shows vaginal estrogen, calling it something viewers should discuss with their doctor. Everything she mentions is prescription-only, and she repeats that clearly.

She describes the testosterone dose as "a tenth of the amount of a man's dose," framing it as appropriate for women because female physiology requires far less. Her tone is educational but personal, and she consistently redirects viewers to their own doctors rather than suggesting they copy her protocol exactly.

Does the science back this up?

Mostly, yes. The estradiol patch, oral progesterone, and low-dose testosterone combination she describes mirrors what major clinical guidelines actually recommend for symptomatic perimenopausal women, particularly those with sleep disruption and genitourinary symptoms.

The Menopause Society (formerly NAMS) 2022 position statement supports transdermal estradiol plus progesterone for women with intact uteri, noting that transdermal delivery avoids first-pass liver metabolism and carries a lower venous thromboembolism risk than oral estrogens (The Menopause Society, 2022, Menopause). Her .075 mg/day patch dose sits within the standard therapeutic range. Oral micronized progesterone at 100-200 mg nightly has documented sleep benefits beyond endometrial protection, likely through GABA-A receptor activity (Schussler et al., 2008, Maturitas). Her dose increase for sleep is clinically consistent with that evidence.

The testosterone piece is more nuanced. There is no FDA-approved testosterone product for women in the United States, so any use is off-label. The evidence base, though growing, is thinner than for estrogen and progesterone.

What did they get wrong (or right)?

She gets more right than wrong, but there is one claim worth scrutinizing. She says testosterone gel is "a tenth of the amount of a man's dose." That framing is roughly accurate in terms of dose magnitude, but it oversimplifies. Female testosterone targets are typically in the physiological range for premenopausal women (roughly 15-70 ng/dL), and dosing is individualized by labs, not just a fixed fraction of male doses. Presenting it as a universal tenth-dose rule could mislead someone into thinking any low dose is safe without monitoring.

She also says "we don't have our own as women" referring to testosterone production. That is incorrect. Women produce testosterone in the ovaries and adrenal glands, and it declines with age and during menopause. It is not that women lack endogenous testosterone, it is that levels drop significantly. Small but real distinction.

What she gets right: she consistently tells viewers her regimen is prescribed by her doctor, stresses individual variation, and does not recommend specific doses for anyone else. That is responsible content for a health-adjacent TikTok.

What should you actually know?

Perimenopause-related HRT is genuinely underused in the United States, partly because of fallout from the 2002 Women's Health Initiative study, which has since been substantially reanalyzed and recontextualized. For healthy women under 60 within 10 years of menopause onset, the benefit-to-risk ratio for hormone therapy is generally favorable for symptom management (Manson et al., 2013, JAMA Internal Medicine).

The four-component regimen she shows, transdermal estradiol, oral progesterone, low-dose testosterone, and vaginal estrogen, reflects a clinically recognized approach for perimenopausal women with systemic and genitourinary symptoms. No single component is experimental, though testosterone for women remains off-label in the US.

  • Transdermal estradiol carries lower clot risk than oral estrogens, per current evidence.
  • Oral micronized progesterone (not synthetic progestins) is associated with better sleep and a more favorable cardiovascular profile.
  • Testosterone for women requires baseline and follow-up labs. It is not a set-and-forget dose.
  • Vaginal estrogen is minimally absorbed systemically and is considered safe even for women with contraindications to systemic HRT.

Bottom line

This is one of the more medically grounded perimenopause videos circulating on TikTok right now. The creator is transparent about her prescriptions, avoids prescribing to viewers, and accurately reflects the general framework of combination HRT. The errors are real but minor. If you are considering any part of this regimen, her instinct to point you toward your own doctor is the one piece of advice worth following without reservation.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Tamsen Fadal · TikTok creator

14.8K views on this video

Here for you if you have any questions! #perimenopause #hormonetherapy

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about transdermal estradiol carries a significantly lower venous thromboembolism risk than?

Transdermal estradiol carries a significantly lower venous thromboembolism risk than oral estrogen formulations, a distinction supported by multiple observational studies including Canonico et al., 2007, Circulation.

What does the video say about oral micronized progesterone at 100-200 mg nightly has sedative properties?

Oral micronized progesterone at 100-200 mg nightly has sedative properties tied to GABA-A receptor activity, making it distinct from synthetic progestins that do not share this mechanism (Schussler et al., 2008, Maturitas).

What does the video say about there?

There is no FDA-approved testosterone product for women in the United States as of 2024; any use is off-label and should involve baseline serum testosterone testing and follow-up monitoring per Endocrine Society guidance.

What does the video say about women do produce endogenous testosterone from ovarian?

Women do produce endogenous testosterone from ovarian and adrenal sources; it declines substantially during perimenopause and menopause, which is distinct from having no production at all.

What does the video say about the 2002 whi findings?

The 2002 WHI findings that discouraged HRT have been substantially reanalyzed; current evidence supports favorable benefit-risk profiles for healthy women under 60 initiating therapy within 10 years of menopause onset (Manson et al., 2013, JAMA Internal Medicine).

What does the video say about vaginal estrogen has minimal systemic absorption?

Vaginal estrogen has minimal systemic absorption and is considered safe for most women, including those with contraindications to systemic hormone therapy, per the Menopause Society 2022 position statement.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Tamsen Fadal, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.